Cargando…
Potentiation of Growth‐inhibitory Activity of 9‐β‐d‐Arabinofuranosyladenine by 2′‐Deoxycoformycin in Human Cultured Cell Lines Derived from Leukemias and Lymphomas
Growth‐inhibitory activity of 2′‐deoxycoformycin (DCF) and 9‐β‐D‐arabinofuranosyladenine (Ara‐A) used either singly or in combination was assessed in 30 human cultured cell lines (seven T‐cell, nine B‐cell, five non‐T, non‐B, and nine myeloid cell lines) derived from leukemias and lymphomas. DCF had...
Autores principales: | Kuroki, Yasumasa, Shimoyama, Masanori, Inaba, Satoshi, Hirose, Masao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917759/ https://www.ncbi.nlm.nih.gov/pubmed/2502523 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02340.x |
Ejemplares similares
-
Deoxycoformycin in the treatment of mature T-cell leukaemias.
por: Dearden, C., et al.
Publicado: (1991) -
Deoxycoformycin in the treatment of mature B-cell malignancies.
por: Dearden, C., et al.
Publicado: (1990) -
Preclinical Assessment of the Treatment of Second-Stage African Trypanosomiasis with Cordycepin and Deoxycoformycin
por: Vodnala, Suman K., et al.
Publicado: (2009) -
Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16
por: Ishida, Yasushi, et al.
Publicado: (1989) -
A Novel Multidrug Resistance in Cultured Leukemia and Lymphoma Cells Detected by a Monoclonal Antibody to 85‐kDa Protein, MRK20
por: Ohtsu, Tomoko, et al.
Publicado: (1989)